Lung Cancer - Non-Small Cell News

Share

Lung Cancer - Non-Small Cell News


Novel PD-1 Inhibitor Opdivo Approved for Treatment of Lung Cancer (March 11, 2015)

CancerConnect News: The Food and Drug Administration has expanded approval of the PD-1 inhibitor Opdivo® (nivolumab) to include treatment of patients who have metastatic squamous non–small cell lung... Continue Reading

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (February 26, 2015)

CancerConnect News: The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted... Continue Reading

NFCR-Support Research Finds New Way to Combat Resistant Lung Cancer (February 11, 2015)

A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding... Continue Reading

Addition of Linifanib to Carboplatin-Paclitaxel Increases Progression-Free Survival and Toxicity in Advanced Nonsquamous NSCLC (February 10, 2015)

In a phase II trial reported in the Journal of Clinical Oncology doctors reported that the addition of linifanib to carboplatin-paclitaxel chemotherapy the outcomes in patients with advanced nonsquamous... Continue Reading

Stereotactic Body Radiation Therapy Improves Survival in Stage IV Non Small Cell Lung Cancer and Represents New Treatment Option (January 21, 2015)

The results of a recent clinical trial published in the Journal of Clinical Oncology in patients with stage IV non small cell lung caner (NSCLC) suggest that combining stereotactic body radiation therapy... Continue Reading

Changing the Face of Lung Cancer: Live Video Chat about Lung Cancer Screening with the Roswell Park Experts (January 21, 2015)

Cancer screening saves lives, but when it comes to lung cancer, early detection has long been a challenge. Thankfully, the outlook for those at highest risk of this deadly disease is improving thanks to... Continue Reading

Non-Small Cell Lung Cancer: The ALCHEMIST Lung Cancer Trials (January 14, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors... Continue Reading

FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer (January 8, 2015)

The U.S. Food and Drug Administration today expanded the approved use of Cyramza (ramucirumab) to treat patients with metastatic non-small cell lung cancer (NSCLC). The most common type of lung cancer,... Continue Reading

Innovative Clinical Trials for Lung Cancer Currently Underway (January 7, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

More Lung Cancer - Non-Small Cell News

Latest Lung Cancer - Non-Small Cell News By Stage


Screening/Prevention

Changing the Face of Lung Cancer: Live Video Chat about Lung Cancer Screening with the Roswell Park Experts (January 21, 2015)

Cancer screening saves lives, but when it comes to lung cancer, early detection has long been a challenge. Thankfully, the outlook for those at highest risk of this deadly disease is improving thanks to new lung cancer screening techniques. Three leading... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors continued to show promise in 2014 and initial... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

Lung Cancer Screening with Low-Dose CT Scan May Lead to Overdiagnosis (December 26, 2013)

Screening for lung cancer with low-dose CT scan may lead to overdiagnosis, according to the results of a study published in JAMA Internal Medicine. Lung cancer is the leading cause of cancer death among both men and women in the United States. The disease... Continue Reading

USPSTF Recommends Lung Cancer Screening in High-Risk Individuals (August 23, 2013)

The U.S. Preventive Services Task Force (USPSTF) recommends screening people who are at high risk for lung cancer with annual low-dose CT scans, which can prevent a substantial number of lung cancer-related deaths. This is a grade B draft recommendation. Lung... Continue Reading

More Screening/Prevention Lung Cancer - Non-Small Cell

Stages I-IIIA

Non-Small Cell Lung Cancer: The ALCHEMIST Lung Cancer Trials (January 14, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for both advanced and early-stage lung cancers are studied.... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors continued to show promise in 2014 and initial... Continue Reading

Innovative Clinical Trials for Lung Cancer Currently Underway (January 7, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for both advanced and early-stage lung cancers are studied.... Continue Reading

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer is the leading cause of cancer death in the U.S.... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer diagnosis? It is important to know the details of... Continue Reading

More Stages I-IIIA Lung Cancer - Non-Small Cell

Stages IIIB-IV

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (February 26, 2015)

CancerConnect News: The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment of people with PD-L1 (Programmed... Continue Reading

NFCR-Support Research Finds New Way to Combat Resistant Lung Cancer (February 11, 2015)

A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported... Continue Reading

Addition of Linifanib to Carboplatin-Paclitaxel Increases Progression-Free Survival and Toxicity in Advanced Nonsquamous NSCLC (February 10, 2015)

In a phase II trial reported in the Journal of Clinical Oncology doctors reported that the addition of linifanib to carboplatin-paclitaxel chemotherapy the outcomes in patients with advanced nonsquamous non–small cell lung cancer (NSCLC). However the... Continue Reading

Stereotactic Body Radiation Therapy Improves Survival in Stage IV Non Small Cell Lung Cancer and Represents New Treatment Option (January 21, 2015)

The results of a recent clinical trial published in the Journal of Clinical Oncology in patients with stage IV non small cell lung caner (NSCLC) suggest that combining stereotactic body radiation therapy (SBRT) with Tarceva (erlotinib) chemotherapy significantly... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors continued to show promise in 2014 and initial... Continue Reading

More Stages IIIB-IV Lung Cancer - Non-Small Cell

Recurrent

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (February 26, 2015)

CancerConnect News: The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment of people with PD-L1 (Programmed... Continue Reading

NFCR-Support Research Finds New Way to Combat Resistant Lung Cancer (February 11, 2015)

A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported... Continue Reading

Addition of Linifanib to Carboplatin-Paclitaxel Increases Progression-Free Survival and Toxicity in Advanced Nonsquamous NSCLC (February 10, 2015)

In a phase II trial reported in the Journal of Clinical Oncology doctors reported that the addition of linifanib to carboplatin-paclitaxel chemotherapy the outcomes in patients with advanced nonsquamous non–small cell lung cancer (NSCLC). However the... Continue Reading

Stereotactic Body Radiation Therapy Improves Survival in Stage IV Non Small Cell Lung Cancer and Represents New Treatment Option (January 21, 2015)

The results of a recent clinical trial published in the Journal of Clinical Oncology in patients with stage IV non small cell lung caner (NSCLC) suggest that combining stereotactic body radiation therapy (SBRT) with Tarceva (erlotinib) chemotherapy significantly... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors continued to show promise in 2014 and initial... Continue Reading

More Recurrent Lung Cancer - Non-Small Cell

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS